Lijnen HR - Search Results

1

Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.

Lijnen HR, Dewerchin M, De Cock F, Collen D. Lijnen HR, et al. Thromb Res. 1990 Feb 1;57(3):333-42. doi: 10.1016/0049-3848(90)90249-c. Thromb Res. 1990. PMID: 2107593

2

Thrombolytic agents.

Collen D, Lijnen HR. Collen D, et al. Among authors: lijnen hr. Thromb Haemost. 2005 Apr;93(4):627-30. doi: 10.1160/TH04-11-0724. Thromb Haemost. 2005. PMID: 15841305 Review.

3

Fibrin-specific fibrinolysis.

Collen D, Lijnen HR. Collen D, et al. Among authors: lijnen hr. Ann N Y Acad Sci. 1992 Dec 4;667:259-71. doi: 10.1111/j.1749-6632.1992.tb51623.x. Ann N Y Acad Sci. 1992. PMID: 1285022 Review. No abstract available.

4

Remaining perspectives of mutant and chimeric plasminogen activators.

Lijnen HR, Collen D. Lijnen HR, et al. Ann N Y Acad Sci. 1992 Dec 4;667:357-64. doi: 10.1111/j.1749-6632.1992.tb51636.x. Ann N Y Acad Sci. 1992. PMID: 1309056 Review.

5

Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.

Vandamme AM, Dewerchin M, Lijnen HR, Bernar H, Bulens F, Nelles L, Collen D. Vandamme AM, et al. Among authors: lijnen hr. Eur J Biochem. 1992 Apr 1;205(1):139-46. doi: 10.1111/j.1432-1033.1992.tb16761.x. Eur J Biochem. 1992. PMID: 1313361 Free article.

6

Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.

Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D. Lu HR, et al. Among authors: lijnen hr. J Am Coll Cardiol. 1992 May;19(6):1350-9. doi: 10.1016/0735-1097(92)90344-m. J Am Coll Cardiol. 1992. PMID: 1342779 Free article.

7

Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator.

Li XK, Lijnen HR, Nelles L, Hu MH, Collen D. Li XK, et al. Among authors: lijnen hr. Biochim Biophys Acta. 1992 Sep 4;1159(1):37-43. doi: 10.1016/0167-4838(92)90072-l. Biochim Biophys Acta. 1992. PMID: 1390910

8

Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.

Dewerchin M, Vandamme AM, Holvoet P, De Cock F, Lemmens G, Lijnen HR, Stassen JM, Collen D. Dewerchin M, et al. Among authors: lijnen hr. Thromb Haemost. 1992 Aug 3;68(2):170-9. Thromb Haemost. 1992. PMID: 1412163

9

Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.

Holvoet P, Laroche Y, Lijnen HR, Van Hoef B, Brouwers E, De Cock F, Lauwereys M, Gansemans Y, Collen D. Holvoet P, et al. Among authors: lijnen hr. Eur J Biochem. 1992 Dec 15;210(3):945-52. doi: 10.1111/j.1432-1033.1992.tb17499.x. Eur J Biochem. 1992. PMID: 1483477 Free article.

10

Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.

Lijnen HR, Li XK, Nelles L, Hu MH, Collen D. Lijnen HR, et al. Eur J Biochem. 1992 Apr 15;205(2):701-9. doi: 10.1111/j.1432-1033.1992.tb16832.x. Eur J Biochem. 1992. PMID: 1533368 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters